Bio-Path Holdings Provides Clinical Update and Expansion Plans
| BPTHDelisted Stock | USD 0.19 0.01 5.00% |
Under 61% of Bio Path's investor base is looking to short. The analysis of overall sentiment of trading Bio Path Holdings otc stock suggests that many investors are alarmed at this time. Bio Path's investing sentiment shows overall attitude of investors towards Bio Path Holdings.
Bio |
Marks Meaningful Progress Across Key Clinical Trials in Multiple Cancer Indications Completes Development of Oncology Molecular Biomarkers and Prepares for Preclinical Obesity Studies HOUSTON, July 08, 2024 -- Bio-Path Holdings, Inc., , a biotechnology company leveraging its proprietary DNAbilize liposomal delivery and antisense technology to develop a portfolio of targeted nucleic acid cancer drugs, today provides an update on the Companys clinical progress and p
Read at finance.yahoo.com
 |
Bio Path Fundamental Analysis
We analyze Bio Path's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bio Path using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bio Path based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Retained Earnings
Retained Earnings Comparative Analysis
Bio Path is currently under evaluation in retained earnings category among its peers. Retained Earnings is a balance sheet account that refers to the portion of company income that is retained by the firm. In other words, it is a part of earnings that is not paid out as dividends or otherwise distributed to owners. Retained Earnings are calculated by adding net income to last period retained earnings and subtracting any dividends paid to owners.
Bio Path Holdings Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Bio Path otc stock to make a market-neutral strategy. Peer analysis of Bio Path could also be used in its relative valuation, which is a method of valuing Bio Path by comparing valuation metrics with similar companies.
Peers
Bio Path Related Equities
| BNTC | Benitec Biopharma | 11.39 | ||||
| CRNX | Crinetics Pharmaceuticals | 7.74 | ||||
| CAPR | Capricor Therapeutics | 6.95 | ||||
| PULM | Pulmatrix | 4.66 | ||||
| ACHV | Achieve Life | 3.37 | ||||
| MBRX | Moleculin Biotech | 1.57 | ||||
| NXTC | NextCure | 1.30 | ||||
| AKTX | Akari Therapeutics | 3.33 |
Check out Bio Path Hype Analysis, Bio Path Correlation and Bio Path Performance. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Other Consideration for investing in Bio OTC Stock
If you are still planning to invest in Bio Path Holdings check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Bio Path's history and understand the potential risks before investing.
| Stocks Directory Find actively traded stocks across global markets | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |